These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 15070128)
1. Abnormal coagulation studies associated with levofloxacin. Report of three cases. Psarros T; Trammell T; Morrill K; Giller C; Morgan H; Allen B J Neurosurg; 2004 Apr; 100(4):710-2. PubMed ID: 15070128 [TBL] [Abstract][Full Text] [Related]
2. Randomized, double-blind, comparative study of levofloxacin and ofloxacin in the treatment of complicated urinary tract infections. Peng MY J Microbiol Immunol Infect; 1999 Mar; 32(1):33-9. PubMed ID: 11561568 [TBL] [Abstract][Full Text] [Related]
7. Levofloxacin: penetration into sputum and once-daily treatment of respiratory tract infections. Nakamori Y; Miyashita Y; Nakatani I; Nakata K Drugs; 1995; 49 Suppl 2():418-9. PubMed ID: 8549384 [No Abstract] [Full Text] [Related]
8. Acute hepatitis associated with oral levofloxacin therapy in a hemodialysis patient. Schwalm JD; Lee CH CMAJ; 2003 Apr; 168(7):847-8. PubMed ID: 12668542 [TBL] [Abstract][Full Text] [Related]
9. [Adverse drug reaction and rational use of levofloxacin: a prospective study]. Zhang Z; Zhen J; Zhan S Zhonghua Liu Xing Bing Xue Za Zhi; 2001 Dec; 22(6):405-7. PubMed ID: 11851050 [TBL] [Abstract][Full Text] [Related]
10. [Pharma-clinics. The drug of the month. Levofloxacin (Tavanic)]. Scheen AJ Rev Med Liege; 2000 Nov; 55(11):1015-7. PubMed ID: 11195704 [TBL] [Abstract][Full Text] [Related]
12. A phase III clinical trial of 0.5% levofloxacin ophthalmic solution versus 0.3% ofloxacin ophthalmic solution for the treatment of bacterial conjunctivitis. Schwab IR; Friedlaender M; McCulley J; Lichtenstein SJ; Moran CT; Ophthalmology; 2003 Mar; 110(3):457-65. PubMed ID: 12623805 [TBL] [Abstract][Full Text] [Related]
13. A comparison of levofloxacin and moxifloxacin use in hospitalized community-acquired pneumonia (CAP) patients in the US: focus on length of stay. Schein J; Janagap-Benson C; Grant R; Sikirica V; Doshi D; Olson W Curr Med Res Opin; 2008 Mar; 24(3):895-906. PubMed ID: 18419876 [TBL] [Abstract][Full Text] [Related]
14. Levofloxacin revisited. Med Lett Drugs Ther; 2011 Jul; 53(1368):55. PubMed ID: 21738109 [No Abstract] [Full Text] [Related]
15. A multicenter, investigator-blinded, randomized comparison of oral levofloxacin and oral clarithromycin in the treatment of acute bacterial sinusitis. Adelglass J; Jones TM; Ruoff G; Kahn JB; Wiesinger BA; Rielly-Gauvin K; Siu CO Pharmacotherapy; 1998; 18(6):1255-63. PubMed ID: 9855324 [TBL] [Abstract][Full Text] [Related]
16. Oral levofloxacin in the treatment of community-acquired pneumonia. Nicodemo AC; Lima Nicodemo E; Idrahim KY Braz J Infect Dis; 2000 Apr; 4(2):61-6. PubMed ID: 10795070 [TBL] [Abstract][Full Text] [Related]
18. Quinolone drug rash in a patient with infectious mononucleosis. Paily R J Dermatol; 2000 Jun; 27(6):405-6. PubMed ID: 10920588 [TBL] [Abstract][Full Text] [Related]
19. The influence of comorbidity on the effect of levofloxacin treatment success of ambulatory respiratory tract infections. Burgmann H; Mayer B; Lukas A; Kumbein F; Oberbauer R Wien Med Wochenschr; 2003; 153(7-8):156-62. PubMed ID: 12764869 [TBL] [Abstract][Full Text] [Related]
20. Fluoroquinolone-induced tendinopathy: also occurring with levofloxacin. Fleisch F; Hartmann K; Kuhn M Infection; 2000; 28(4):256-7. PubMed ID: 10961538 [No Abstract] [Full Text] [Related] [Next] [New Search]